- Home
- IPW vs ICCC Comparison
IPW vs ICCC Comparison
Compare IPW & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- ICCC
- Stock Information
- Founded
- IPW 2018
- ICCC 1982
- Country
- IPW United States
- ICCC United States
- Employees
- IPW N/A
- ICCC N/A
- Industry
- IPW Catalog/Specialty Distribution
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- IPW Consumer Discretionary
- ICCC Health Care
- Exchange
- IPW Nasdaq
- ICCC Nasdaq
- Market Cap
- IPW 29.3M
- ICCC 28.0M
- IPO Year
- IPW 2021
- ICCC 1987
- Fundamental
- Price
- IPW $0.80
- ICCC $4.43
- Analyst Decision
- IPW Strong Buy
- ICCC
- Analyst Count
- IPW 1
- ICCC 0
- Target Price
- IPW $2.75
- ICCC N/A
- AVG Volume (30 Days)
- IPW 236.8K
- ICCC 22.8K
- Earning Date
- IPW 02-12-2025
- ICCC 11-13-2024
- Dividend Yield
- IPW N/A
- ICCC N/A
- EPS Growth
- IPW N/A
- ICCC N/A
- EPS
- IPW N/A
- ICCC N/A
- Revenue
- IPW $78,571,632.00
- ICCC $23,838,001.00
- Revenue This Year
- IPW $8.31
- ICCC N/A
- Revenue Next Year
- IPW $77.15
- ICCC N/A
- P/E Ratio
- IPW N/A
- ICCC N/A
- Revenue Growth
- IPW N/A
- ICCC 46.37
- 52 Week Low
- IPW $0.40
- ICCC $3.34
- 52 Week High
- IPW $3.65
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- IPW 41.40
- ICCC 52.56
- Support Level
- IPW $0.88
- ICCC $4.58
- Resistance Level
- IPW $1.02
- ICCC $5.23
- Average True Range (ATR)
- IPW 0.11
- ICCC 0.50
- MACD
- IPW 0.03
- ICCC -0.01
- Stochastic Oscillator
- IPW 17.25
- ICCC 32.85
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.